Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Ohara K, Rendeiro AF, Bhinder B, Eng KW, Ravichandran H, Nguyen D, et al. The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis. Nat Commun. 2024;15(1):2009.

Nooruzzaman M, Johnson KE, Rani R, Finkelsztein EJ, Caserta LC, Kodiyanplakkal RP, et al. Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections. medRxiv. 2024.

Daman AW, Antonelli AC, Redelman-Sidi G, Paddock L, Cheong JG, Jurado LF, et al. Microbial cancer immunotherapy reprograms hematopoietic stem cells to enhance anti-tumor immunity. bioRxiv. 2024.

Cavallaro J, Singha S, Chakrabarti B, Gopalakrishnan E, Harshan M, Pramanik BK, et al. Symptomatic infratentorial ependymal cyst arising from the medulla: a case report with review of literature. Neurochirurgie. 2024;70(4):101553.

Kim D, Thrall MJ, Michelow P, Schmitt FC, Vielh PR, Siddiqui MT, et al. The current state of digital cytology and artificial intelligence (AI): global survey results from the American Society of Cytopathology Digital Cytology Task Force. J Am Soc Cytopathol. 2024;13(5):319-328.

Morales AE, Gumenick R, Genovese CM, Jang YY, Ouedraogo A, de Garayo MI, et al. Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP. PLoS Pathog. 2024;20(1):e1011881.

Kudman S, Semaan A, Assaad MA, Gogineni S, M Martin L, Mathew S, et al. Optimization of Fluorescence In Situ Hybridization Protocols in the Era of Precision Medicine. Curr Protoc. 2024;4(6):e1093.

Morse KW, Sun J, Hu L, Bok S, Debnath S, Cung M, et al. Development of Murine Anterior Interbody and Posterolateral Spinal Fusion Techniques. J Bone Joint Surg Am. 2024.

Kubiak JM, Klevay M, Hilt EE, Ferrieri P. Acute Meningoencephalitis Associated with Borrelia miyamotoi, Minnesota, USA. Emerg Infect Dis. 2024;30(7):1472-1474.

Deng Q, Lakra P, Gou P, Yang H, Meydan C, Teater M, et al. SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions. Cancer Cell. 2024.